Ergoteles’s Pulse Biosciences PLSE Stock Holding History

Ergoteles’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-37,096	Closed	-$85K	–	1788
2022 Q3	$85K	Sell	37,096 -27,587	-43%	-$44.8K	﹤0.01%	1401
2022 Q2	$99K	Buy	+64,683	New	+$163K	﹤0.01%	1514

Other funds holding PLSE

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GAM

Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Ergoteles's PLSE Position: Q4 2022 in Review

Ergoteles sold out of Pulse Biosciences (PLSE) in Q4 2022, closing a stake of 37,096 shares — an estimated $85K sold.

Ergoteles first reported a position in PLSE in Q2 2022 and held it in 2 quarters. The position peaked at $99K in Q2 2022. 29 funds tracked by Wall St. Rank hold PLSE as of Q4 2022.

Ergoteles reported no remaining Pulse Biosciences position as of Q4 2022 after selling out during the quarter.
Ergoteles sold 37,096 Pulse Biosciences shares in Q4 2022, an estimated $85K.
Ergoteles first reported a position in Pulse Biosciences in Q2 2022 and held it in 2 quarters.
Ergoteles's Pulse Biosciences position peaked at $99K in Q2 2022.
29 funds tracked by Wall St. Rank held Pulse Biosciences as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.